Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling

Oncogene

Volumn 26, Issue 38, 2007, Pages 5587-5595

  Endo, Y ^a   Marusawa, H ^a   Kinoshita, K ^b   Morisawa, T ^a   Sakurai, T ^a   Okazaki, I M ^a   Watashi, K ^a   Shimotohno, K ^a   Honjo, T ^a   Chiba, T ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Shiga Medical Center Research Institute   (Japan)

Author keywords

Activation induced cytidine deaminase; Chronic hepatitis; Hepatitis C virus; Hepatocellular carcinoma; NF B; TNF

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CORE PROTEIN; CYTIDINE DEAMINASE; CYTOKINE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; MUTAGENESIS; NONHUMAN; ONCOGENE C MYC; PIM1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STIMULATION;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CYTIDINE DEAMINASE; GENE EXPRESSION; HEPACIVIRUS; HEPATOCYTES; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; MICE; MICE, TRANSGENIC; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS; MUS;

EID: 34547941093     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210344     Document Type: Article

References (44)

1. Aly HH, Watashi K, Hijikata M, Kaneko H, Takada Y, Egawa H et al. (2007). Serum-derived hepatitis Cvirus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol 46: 26-36.
2. Balkwill F, Mantovani A. (2001). Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
3. Coulouarn C, Gomez-Quiroz LE, Lee JS, Kaposi-Novak P, Conner EA, Goldina TA et al. (2006). Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis. Hepatology 44: 1003-1011.
4. Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature 420: 860-867.
5. Dedeoglu F, Horwitz B, Chaudhuri J, Alt FW, Geha RS. (2004). Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int Immunol 16: 395-404.
6. Doi T, Kinoshita K, Ikegawa M, Muramatsu M, Honjo T. (2003). De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination. Proc Natl Acad Sci USA 100: 2634-2638.
7. Feitelson MA. (2006). Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett 239: 10-20.
8. Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L, Moreno-Otero R, Alonso JL, Yague E et al. (1994). Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 179: 841-848.
9. Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE et al. (2003). Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 101: 3574-3580.
10. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
11. Heintel D, Kroemer E, Kienle D, Schwarzinger I, Gleiss A, Schwarzmeier J et al. (2004). High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 18: 756-762.
12. Honjo T, Kinoshita K, Muramatsu M. (2002). Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 20: 165-196.
13. Ishii N, Watashi K, Hishiki T, Goto K, Inoue D, Hijikata M et al. (2006). Diverse effects of cyclosporine on hepatitis C virus strain replication. J Virol 80: 4510-4520.
14. Karin M, Greten FR. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
15. Kinoshita K, Honjo T. (2001). Linking class-switch recombination with somatic hypermutation. Nat Rev Mol Cell Biol 2: 493-503.
16. Kinoshita K, Nonaka T. (2006). The dark side of activationinduced cytidine deaminase: relationship with leukemia and beyond. Int J Hematol 83: 201-207.
17. Kotani A, Okazaki IM, Muramatsu M, Kinoshita K, Begum NA, Nakajima T et al. (2005). A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Proc Natl Acad Sci USA 102: 4506-4511.
18. Kou T, Marusawa H, Kinoshita K, Endo Y, Okazaki IM, Ueda Y et al. (2007). Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int J Cancer 120: 469-476.
19. Lengauer C, Kinzler KW, Vogelstein B. (1998). Genetic instabilities in human cancers. Nature 396: 643-649.
20. Loeb LA, Loeb KR, Anderson JP. (2003). Multiple mutations and cancer. Proc Natl Acad Sci USA 100: 776-781.
21. Machida K, Cheng KT, Sung VM, Shimodaira S, Lindsay KL, Levine AM et al. (2004). Hepatitis Cvirus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 101: 4262-4267.
22. Martin A, Bardwell PD, Woo CJ, Fan M, Shulman MJ, Scharff MD. (2002). Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415: 802-806.
23. Martin A, Scharff MD. (2002). Somatic hypermutation of the AID transgene in B and non-B cells. Proc Natl Acad Sci USA 99: 12304-12308.
24. Marusawa H, Hijikata M, Chiba T, Shimotohno K. (1999). Hepatitis Cvirus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 73: 4713-4720.
25. Marusawa H, Hijikata M, Watashi K, Chiba T, Shimotohno K. (2001). Regulation of Fas-mediated apoptosis by NF-kappaB activity in human hepatocyte derived cell lines. Microbiol Immunol 45: 483-489.
26. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K et al. (2000). Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31: 488-495.
27. Matsumoto T, Marusawa H, Endo Y, Ueda Y, Matsumoto Y, Chiba T. (2006). Expression of APOBEC2 is transcriptionally regulated by NF-kappaB in human hepatocytes. FEBS Lett 580: 731-735.
28. Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS. (1993). Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 53: 1719-1723.
29. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. (2000). Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
30. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO et al. (1999). Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274: 18470-18476.
31. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K et al. (2003). Constitutive expression of AID leads to tumorigenesis. J Exp Med 197: 1173-1181.
32. Okazaki IM, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T. (2002). The AID enzyme induces class switch recombination in fibroblasts. Nature 416: 340-345.
33. Pahl HL. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
34. Pelengaris S, Khan M, Evan G. (2002). c-MYC: more than just a matter of life and death. Nat Rev Cancer 2: 764-776.
35. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S et al. (2004). NF-kappaB functions as a tumour promoter in inflammation- associated cancer. Nature 431: 461-466.
36. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O et al. (2000). Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
37. Ta VT, Nagaoka H, Catalan N, Durandy A, Fischer A, Imai K et al. (2003). AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 4: 843-848.
38. Tanaka Y, Marusawa H, Seno H, Matsumoto Y, Ueda Y, Kodama Y et al. (2006). Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem Biophys Res Commun 341: 314-319.
39. Tateno C, Takai-Kajihara K, Yamasaki C, Sato H, Yoshizato K. (2000). Heterogeneity of growth potential of adult rat hepatocytes in vitro. Hepatology 31: 65-74.
40. Teng B, Burant CF, Davidson NO. (1993). Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260: 1816-1819.
41. Thorgeirsson SS, Grisham JW. (2002). Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-346.
42. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G et al. (1992). Serum levels of cytokines in chronic liver diseases. Gastroenterology 103: 264-274.
43. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T et al. (1993). Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328: 1797-1801.
44. Yoshikawa K, Okazaki IM, Eto T, Kinoshita K, Muramatsu M, Nagaoka H et al. (2002). AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296: 2033-2036.